Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis

NCT04083482 is registered in ClinicalTrials.gov with First People's Hospital of Chenzhou as lead sponsor.

NCT NCT04083482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04083482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis
Lead sponsor
First People's Hospital of Chenzhou
Phase
Not applicable
Overall status
Unknown status
Start date
August 20, 2018
Completion date
December 31, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care unit